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abstract
CONTEXT: Many factors like exposure to UV radiation, climatic con-
ditions, genetic predisposition, immunological state and, more re-
cently, the presence of HPV have been implicated in the genesis of
some lesions of the conjunctiva, especially the carcinoma.
OBJECTIVE: To evaluate the presence of HPV DNA in acquired le-
sions of the conjunctiva and in normal mucosa.
TYPE OF STUDY: Cross-sectional study.
SETTING: A public university referral center (the Ophthalmology Ser-
vice of the A.C. Camargo Hospital - A. Prudente Foundation, São
Paulo).
PARTICIPANTS: Thirty patients with acquired lesions of the conjunc-
tiva and 60 matched controls (by age and sex) were evaluated in
this study, from June 1993 to March 1995.
PROCEDURES: The detection of HPV DNA in the normal conjunctiva
and in acquired lesions was done by the PCR technique and dot blot
hybridization. The material was collected by scraping the normal
mucosa and the surface of the lesions. A fragment of fresh frozen
tissue and paraffin embedded specimens of each lesion were also
included.
MAIN MEASUREMENTS: The association between the HPV infec-
tion and the presence or absence of conjunctival lesions.
RESULTS: Sequences of HPV DNA were detected in 4 of the 31
lesions evaluated (12.9%) and in the healthy mucosa of one indi-
vidual of the control group (1.6%). HPV type 16 was detected in 2
carcinomas and in the normal mucosa of one individual of the con-
trol group. HPV type 11 was demonstrated in 2 papillomas of one
patient with lesions in both eyes.
CONCLUSIONS: The low frequency of HPV DNA found in the le-
sions of this sample and the detection of the viral genome in the
normal mucosa indicate that there is a weak possibility of associa-
tion between HPV infection and the carcinoma of the conjunctiva.
KEY WORDS: Human papillomavirus. Polymerase chain reaction.
Epithelial lesions. Conjunctiva.
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INTRODUCTION
Human papillomavirus (HPV) is a DNA virus
from the Papovaviridae family that has been identi-
fied in a variety of epithelial lesions of the skin and
mucosa. Up to the present day, more than 70 types of
HPV have been isolated, some with known oncogenic
potential infecting the genital tract, urinary bladder,
larynx, oral cavity and conjunctiva.1 The potential for
malignant transformation of some HPV is related to
its ability to bind tumor suppressor proteins in the
host, thus affecting the cellular cycle of the infected
cells.2 The HPV already identified in the conjunctiva
are of the high risk types 16 and 18 and the low risk
types 6 and 11.1,3
The first demonstration of HPV in the conjunc-
tiva was in the 1980’s, from the identification of the
capsid antigen in papillomas by employing immuno-
histochemistry.4,5,6 In subsequent years, authors in
Europe and U.S.  identified and typed HPV DNA in
papillomas, dysplasias and carcinomas of the conjunc-
tiva and also in normal mucosa, using techniques of
molecular hybridization.3, 7-15
The prevalence of some HPV is universal for
some lesions and for some specific sites like the geni-
tal tract. However, the frequency of HPV DNA detec-
tion in the conjunctiva varies considerably.1
We proposed to investigate the presence of
HPV DNA in a sample of epithelial lesions of the con-
junctiva, motivated by the scarcity of publications and
the variability of the results relating to HPV findings
in the conjunctiva.
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METHODS
A cross-sectional study was conducted in order
to search for HPV DNA in epithelial lesions of the con-
junctiva, in a sample of patients referred to the Oph-
thalmology Service of the Cancer Hospital - Antonio
Prudente Foundation, São Paulo, from June 1993 to
March 1995.
Three samples of each lesion were collected for
analysis and included: swab, fresh frozen fragment of
the surgical specimen and paraffin-embedded mate-
rial. Swabs of the conjunctiva, apparently normal, of
the opposite eye were also performed, as well as in
sixty matched controls. The controls were matched by
age (+/- 3 years) and sex.
Swab. After the instillation of anesthetic drops,
a swab was performed over the lesion in the affected
eyes and between the limbus and inferior fornix in the
fellow eye using an appropriate spiral brush
(Cytobrush, Medscand, Sweden). After the swab had
been performed, the Cytobrush was immediately im-
mersed in Tris solution (10mM, EDTA 1mM, pH 7.5).
Samples were stored at 4oC until analysis.
Fresh frozen fragment of the surgical specimen and paraf-
fin-embedded material. After removal, the lesions were sec-
tioned using a surgical blade, from limbus to fornix or
from limbus to palpebral canthus, over a rigid surface.
About 1/3 of the specimen was put into a dry vial and
sent for immediate freezing at -20oC. The other 2/3 were
put into formaldehyde 10% and sent for histopatho-
logical analysis by the Department of Pathology of the
Cancer Hospital. The surgical specimens were evalu-
ated by optical microscopy after staining with hema-
toxylin-eosin.
The DNA of the sample was isolated using ionic
change columns in the “Glass Max DNA Isolation Spin
Cartridge System” (Gibco / BRL, Gaithersburg, MD,
USA). The DNA of the samples was submitted to PCR
with consensus primers MY 9/11,16 which amplify 450
bp of L1 of several types of HPV, in order to verify the
presence of HPV DNA. The primers G-73 and G-74,
which amplify 268 of in the human B globin gene, were
employed as internal controls of the integrity and suit-
ability of the DNA in each sample. The typing of differ-
ent HPV was done by dot blot hybridization using 28
specific-type probes,16 or through the digestion of the
PCR products by restriction enzymes2 capable of iden-
tifying about 40 different types of HPV.
For the paraffin-embedded tissue the GP 5+ /
6+ primers were also employed, which amplify a frag-
ment of 150 bp of the L1 gene of most genital HPVs.17
Positive controls included samples of genital tu-
mor with known HPV DNA content, and negative con-
trols included normal epithelial tissue, HPV-negative.
Commercially available cervical-carcinoma cell lines
(SiHa, HeLa cells) were used as additional controls.
Statistical Methods
The Chi-square test was used to access the sig-
nificance of the association between the HPV infection
and the presence or absence of conjunctival lesions.
RESULTS
Thirty-one lesions were obtained from thirty
patients, with ages varying from 10 to 82 years (mean
49.7 years, median 54, SD 18.7). In the control group
the age varied from 10 to 83 years (mean 49.7, median
54.5, SD 18.2). Seventeen cases (and 34 controls) were
men and thirteen were women (26 controls), produc-
ing a proportion of 56.6% male to 43.3% female.
Twenty patients (66.7%) were white and 10 (33%)
non-white. There were no Negro or Oriental patients
in this sample. Twenty-nine patients (96.7%) had uni-
lateral lesions and one (3.3%) had lesions in both eyes.
The left eye was involved in 18 cases (58%). Fourteen
lesions were new (45.1%), 15 recurrent (48.4%) and 2
Table 1. Histopathological diagnosis of conjunctival
lesions analyzed for the presence of HPV DNA, the
frequency of its association and type of HPV found
Diagnosis no. lesions freq. HPV DNA HPV type
ca “in situ” 9 0 --
invasive scc 10 2 16
bcc 1 0 --
severe dysplasia 2 0 --
mild dysplasia 1 0 --
papilloma 2 2 11
non-melanotic nevus 2 0 --
chronic inflammation 3 0 --
pyogenic granuloma 1 0 --
Total (%) 31 4(12%)
Legend: ca = carcinoma; scc = squamous cell carcinoma; bcc = basal
cell carcinoma of the eyelid infiltrating the conjunctiva.
Table 2. Distribution of patients and controls of the
study with conjunctival infection by HPV, according to
the age (years), sex, race, the histopathologic diagnosis
of their conjunctival lesions and the type of HPV found
I.D. Case 1 Case 16 Case 26 Control 10b
sex M F M M
age(years) 10 15 40 70
race nw nw w w
diagnosis scc papilloma scc no lesion
HPV type 16 11 16 16
Legend:  nw = non-white; w = white; scc = squamous cell carcinoma.
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were considered residuals (6.5%) from clinical evidence
and histopathological proof.
All the lesions were located in the palpebral fis-
sure. In 24 cases (77.4%) the lesions involved both the
bulbar conjunctiva and the limbus, simultaneously.
 Optical microscopy evaluation of hematoxylin-
eosin stained sections identified: 10 invasive squa-
mous cell carcinomas, 9 carcinomas in situ, 1 basal
cell carcinoma of the eyelid infiltrating the conjunc-
tiva, 3 dysplasias, 2 papillomas, 2 non-melanotic nevi
and 4 inflammatory lesions. The last two were included
in this sample because they corresponded to elevated
lesions appeared just at the site of previously resected
carcinomas (Table 1).
Sequences of HPV DNA were detected in 4 of the
31 evaluated lesions (12.9%) and in the healthy mucosa
of an individual in the control group (1.6%) (P = 0.07).
DNA of HPV type 11 was identified in 2 papillo-
mas of one patient with lesions in both eyes. DNA of
HPV 16 was detected in 2 invasive squamous cell car-
cinomas and in the swab of the apparently healthy
conjunctiva in one person of the control group. A viral
genome was detected and identified in the paraffin-
embedded material of 4 lesions, in the swab of 3 le-
sions and in the frozen tissue of 2 out of 4 lesions.
Table 2 shows the distribution of individuals with HPV
conjunctival infection according to their identification
characteristics, the histopathologic diagnosis and the
type of HPV found.
DISCUSSION
The frequency of HPV DNA detection in the con-
junctiva varies considerably, as has been shown by
some investigators over the last few years (Table 3).
In this sample, of the 29 types of HPV researched,
including some that have not been numbered yet, only
the HPV types 11 and 16 were detected. According to
the literature these types of HPV are also the ones
most frequently found in the conjunctiva.
We detected HPV DNA in 4 of the 31 lesions
(12.9%) and in the apparently healthy conjunctiva of
one individual of the control group (1.6%). The DNA
of HPV 11 was detected in 2 papillomas (in one pa-
tient). The HPV 16 was found in 2 invasive carcinomas
and in the conjunctiva of one individual of the control
group. We did not detect HPV DNA in the fellow eye of
the patients bearing conjunctival lesions.
The detection of HPV in the apparently healthy
mucosa has previously been reported in the literature
from different anatomical locations such as the cervix
and larynx, as well as the conjunctiva.3,18,19
The latency of the virus can be demonstrated by
the detection of HPV DNA in the mucosa in the ab-
sence of clinical lesions and subclinical changes.20
About 15 to 40% of women with positive HPV in the
cervix do not have any kind of mucosal change.21,22
In the conjunctiva, investigators have identified
HPV DNA 16 in swabs from clinically uninvolved eyes
and have also reported persistent infection by HPV for
many years after successful eradication of epithelial
neoplasia, without any recurrences.3 The significance
and the implications of virus latency in the conjunc-
tiva, as in other mucosa, need additional investigation.
The modes of HPV transmission, depending on
the HPV type and location, may involve casual physi-
cal contact, sexual contact and perinatal vertical trans-
mission. The access of HPV to the conjunctiva is still
an object of investigation. Transmission to the con-
junctiva may occur as a result of fetal passage through
an infected birth canal or by ocular contact with con-
taminated hands or objects.23 The former mechanism
could easily explain the conjunctival papillomas found
in children, but not necessarily those of adults. The
Table 3. Distribution of studies concerning HPV in lesions of the conjunctiva,
published between 1986 and 1994, according to the first author, the histopathologic diagnosis
of the lesions, the frequency and type of HPV found and the technique employed
Reference HPV type frequency diagnosis technique
Naghashfar,8 1986. 6 1/1 papilloma SB / ISH
McDonnell,6 1986. 16 15/23 papilloma ISH
0/28 dysplasia/ca ISH
McDonnell,9 1989. 16 12/16 dysplasia/ca PCR
Lauer,10 1990. 16,18 4/5 dysplasia/ca PCR
Odrich,11 1991. 16 3/3 dysplasia/ca
McDonnell,3 1992. 16 35/42 dysplasia/ca PCR
37/42
Mincione,12 1992. 6,11 2/4 papilloma ISH
Tuppurainen,13 1992. 6,11,16,18 0/4 carcinoma PCR / ISH
Cha,15 1994. 16 21/31 dysplasia/ca PCR
18 2/31
Legend:  SB = Southern blot; ISH = in situ hybridization; PCR = polymerase chain reaction.
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presence of HPV 6 and 11 in adult conjunctival papil-
lomas may reflect either activation of a latent HPV in-
fection acquired as above, or an infection acquired
later in life by transmission from other mucosal sites
through either of the latter mechanisms.8,22,24
The detection of HPV types 6 and 11 in papil-
loma is very common, and these two types are prob-
ably responsible for the majority of the papillomas of
the human conjunctiva, at least in children and young
adults.25 On the other hand, the variations in the fre-
quency of HPV detection for the types 16 and 18, in
dysplasias and carcinomas, are significant.1
There are papillomas of viral origin and non-vi-
ral ones. Though they cannot be distinguished from a
histopathological viewpoint, viral papilloma can be
suspected if they occur in children or young adult, as
they are generally pediculous, bilateral, multiple, lo-
cated in the conjunctival fornices or in the eyelid and
sometimes suffer spontaneous regression. The non-
infectious papillomas occur in adults. They are diffuse
or sessile, develop in the bulbar conjunctiva and ac-
cording to some authors can represent a benign squa-
mous hyperplasia or a dysplasia.23
The carcinomas and the precursor lesions, unlike
the papillomas, do not present known characteristics that
could give the suspicion of any association with HPV.
The HPV seem to be associated with some, but not all
carcinomas. Some authors have found that certain car-
cinomas, especially the verrucous types in the tonsil and
larynx, are in their great majority associated with HPV,
while other types do not seem to have viral etiology.26
In our study we did not observe any similarities
among the lesions, nor even among the patients with
HPV-positive lesions, that could put them in a homog-
enous group distinct from the other individuals and
from the controls of the study.
The HPV-positive lesions were not different from
the others in terms of their appearance, as the major-
ity were presented as elevated vascularized gelatinous
masses. Nor did the timing of their appearance dis-
tinguish them very well, with this being at about 7
months for HPV-positive lesions (variation: 1 to 12
months) and 9 months for the HPV-negative ones
(variation: 1 to 48 months).
The recurrence of epithelial neoplasia of the
conjunctiva is considered common.27,28,29 Some authors
have detected a high frequency of association of re-
current lesions with some HPV.15  In spite of a signifi-
cant proportion of recurrent lesions in our sample
(48.4%),  HPV was found in none of them. The HPV-
positive lesions corresponded to the first conjuncti-
val tumors presented by those patients at the time of
our initial evaluation.
We decided to investigate the HPV DNA using 3
samples from each lesion as it is known that viral DNA
can be found either superficially and diffusely dispersed
in the epithelium, or concentrated in a focal way in a
group of cells. The samples included: swab of the le-
sion, a frozen fragment of the surgical specimen and
the paraffin-embedded material. HPV DNA was found
in all the paraffin-embedded tissue from the positive
lesions, in the swabs of 3 out of 4 lesions, and in the
frozen tissue from 2 of them. Due to the observation of
discordance in relation to HPV DNA positivity in differ-
ent samples from the same lesion (positive biopsy,
negative swab and vice versa), investigators have sug-
gested the collection of material by either swab or bi-
opsy, in order to obtain more conclusive results.30,31
The polymerase chain reaction or PCR has been
widely used over recent years for the detection of HPV
in cutaneous and mucosal lesions.1 We used the PCR
technique in our study because it shows the most sen-
sitivity of all the available methods. However, exactly
because of its sensitivity, false-positive results coming
from contamination are relatively common. Thus, rig-
orous control of the assay conditions is necessary.32 In
order to avoid cross contamination among the samples,
changes of materials like gloves and aerosol-free tips
were routinely made at all steps of the assay.
Discrepancies in the prevalence of HPV detected
by PCR may be related to different variables such as:
primers used, reaction conditions, cycling parameters
and magnesium concentration. Thus, all these param-
eters were rigorously observed and controlled in this
study. Aspects inherent to the samples and to the
method were also analyzed.
The amplification of the human globin gene,
which is present in all cells, was applied to all biologi-
cal samples and proved that the gene material was
sufficient and adequate for the DNA study, thus ex-
cluding false-negative results.
We decided on an evaluation of the L1 gene, which
is not lost at the time of virus integration into the host
cell. Such deletion can potentially happen with the com-
monly used E1/E2 genes. The use of the latter could in
some cases explain certain false-negative results.11
The frequency of the HPV found in epithelial le-
sions from our sample can be considered low, when
we compare this to the findings of other studies.
Some evidence supports the hypothesis that the
HPV does not act alone in the development of epithelial
lesions of the conjunctiva, like findings of HPV DNA in
dysplasias and carcinomas in such variable frequencies,
its detection in apparently healthy mucosa, and its per-
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sistent positivity years after the removal of the lesions.
Exposure to excessive ultraviolet-B light (UV-B)
has been identified by numerous previous studies as a
major etiological factor in the development of ocular
surface squamous neoplasia.33 It may be that ultravio-
let light or other carcinogens act in concert with viral
infection to transform cells.9 In fact, the role of HPV in
the conjunctiva has yet to be proven. The close asso-
ciation of some human papillomavirus (HPV 16) with a
majority of cervical carcinomas implies an important
role for the virus in this type of cancer. However, in rela-
tion to the epithelial neoplasia of the conjunctiva, this
can not be considered as a verisimilitude. At present,
the scarcity of the studies on HPV in the conjunctiva,
the variations in methods employed, and the
interlaboratory variations for the same method, dem-
onstrated in the literature, do not permit the establish-
ment of an etiological relationship of HPV with con-
junctival lesions. The present study leads us to suggest
that some epithelial lesions of the conjunctiva have no
association with the human papillomavirus.
CONCLUSIONS
The low frequency of HPV found in the epithelial
lesions of our sample and the detection of the viral ge-
nome in normal conjunctiva lead us to suggest that
some conjunctival carcinomas have no association with
the human papillomavirus. The etiopathogenic role of
these viruses in the conjunctiva is yet to be established.
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resumo
CONTEXTO: Vários fatores como exposição à radiação ultravioleta,
condições climáticas, predisposição genética, estado imunológico
e, mais recentemente, a presença do papilomavírus humano têm
sido implicados na etiopatogênese das lesões neoplásicas da
conjuntiva, em especial dos carcinomas.
OBJETIVO: Avaliar a presença de DNA do HPV em uma série de
lesões adquiridas da conjuntiva e na mucosa clinicamente normal.
TIPO DE ESTUDO: Estudo transversal.
LOCAL: Centro de referência universitário (Serviço de Oftalmologia
do Hospital A. C. Camargo - Fundação Antônio Prudente).
PARTICIPANTES:  Trinta pacientes com lesões epiteliais adquiridas
da conjuntiva e 60 controles pareados por sexo e idade foram
incluídos no estudo, no período de Junho de 1993 a Março de
1995.
PROCEDIMENTOS: A pesquisa de DNA do HPV, na conjuntiva nor-
mal e nas lesões adquiridas, procedeu-se através das técnicas de
reação de polimerização em cadeia (PCR) e hibridização em pontos.
O material para estudo foi coletado por esfregaço da mucosa nor-
mal e da superfície das lesões conjuntivais. Os fragmentos
congelados da peça cirúrgica e os espécimes incluídos em parafina
de cada uma das lesões foram igualmente incluídos na investigação.
VARIÁVEIS ESTUDADAS: A associação entre a infecção pelo HPV
e a presença ou não de lesões conjuntivais.
RESULTADOS: Seqüências do DNA do HPV foram detectadas em 4
de 31 lesões avaliadas (12,9%) e na mucosa clinicamente sadia de
um indivíduo do grupo controle (1,6%) (P = 0,07). O HPV tipo 16
foi detectado em dois carcinomas invasivos e na mucosa clinicamente
normal de um indivíduo do grupo controle. O HPV tipo 11 foi
identificado em dois papilomas de um único paciente portador de
lesões em ambos os olhos.
CONCLUSÕES:  A baixa freqüência do DNA do HPV, encontrada
nas lesões desta amostra, e a detecção do genoma viral na mucosa
clinicamente sadia indicam que há uma fraca possibilidade de
associação entre a infecção pelo HPV e os carcinomas da conjuntiva.
PALAVRAS-CHAVE:  Papilomavírus humano. Reação de
polimerização em cadeia. Lesões epiteliais. Conjuntiva.
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